266 related articles for article (PubMed ID: 18089795)
1. BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.
Omidvar N; Kogan S; Beurlet S; le Pogam C; Janin A; West R; Noguera ME; Reboul M; Soulie A; Leboeuf C; Setterblad N; Felsher D; Lagasse E; Mohamedali A; Thomas NS; Fenaux P; Fontenay M; Pla M; Mufti GJ; Weissman I; Chomienne C; Padua RA
Cancer Res; 2007 Dec; 67(24):11657-67. PubMed ID: 18089795
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?
Rassool FV; Gaymes TJ; Omidvar N; Brady N; Beurlet S; Pla M; Reboul M; Lea N; Chomienne C; Thomas NS; Mufti GJ; Padua RA
Cancer Res; 2007 Sep; 67(18):8762-71. PubMed ID: 17875717
[TBL] [Abstract][Full Text] [Related]
3. Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromes.
Le Pogam C; Krief P; Beurlet S; Soulié A; Balitrand N; Cassinat B; Cavé H; Kosmider O; Setterblad N; Leboeuf C; Sarda-Mantel L; Hervatin F; Merlet P; Noguera ME; Janin A; Pla M; Fontenay M; Adès L; Fenaux P; Chomienne C; Padua RA; Omidvar N
Leuk Res; 2013 Mar; 37(3):312-9. PubMed ID: 23153525
[TBL] [Abstract][Full Text] [Related]
4. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
6. BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.
Beurlet S; Omidvar N; Gorombei P; Krief P; Le Pogam C; Setterblad N; de la Grange P; Leboeuf C; Janin A; Noguera ME; Hervatin F; Sarda-Mantel L; Konopleva M; Andreeff M; Tu AW; Fan AC; Felsher DW; Whetton A; Pla M; West R; Fenaux P; Chomienne C; Padua RA
Blood; 2013 Oct; 122(16):2864-76. PubMed ID: 23943652
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
Bernasconi P
Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
[TBL] [Abstract][Full Text] [Related]
8. Molecular bases of myelodysplastic syndromes: lessons from animal models.
Komeno Y; Kitaura J; Kitamura T
J Cell Physiol; 2009 Jun; 219(3):529-34. PubMed ID: 19259975
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of ras gene activation in myeloid leukemic cells.
Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP
Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.
Lorenzo F; Nishii K; Monma F; Kuwagata S; Usui E; Shiku H
Leuk Res; 2006 Oct; 30(10):1235-9. PubMed ID: 16533529
[TBL] [Abstract][Full Text] [Related]
12. Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.
Blatt K; Herrmann H; Hoermann G; Willmann M; Cerny-Reiterer S; Sadovnik I; Herndlhofer S; Streubel B; Rabitsch W; Sperr WR; Mayerhofer M; Rülicke T; Valent P
Clin Cancer Res; 2014 Jul; 20(13):3589-602. PubMed ID: 24799522
[TBL] [Abstract][Full Text] [Related]
13. [Activation of ras oncogene in myelodysplastic syndrome and acute myelogenous leukemia].
Hirai H; Hirano N; Yazaki Y
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1090-7. PubMed ID: 2053767
[TBL] [Abstract][Full Text] [Related]
14. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations.
Arber DA; Slovak ML; Popplewell L; Bedell V; Ikle D; Rowley JD;
Am J Clin Pathol; 2002 Feb; 117(2):306-13. PubMed ID: 11863228
[TBL] [Abstract][Full Text] [Related]
15. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
Preisler HD
Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
[No Abstract] [Full Text] [Related]
16. Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes.
Shuai X; Zhou D; Shen T; Wu Y; Zhang J; Wang X; Li Q
Cancer Genet Cytogenet; 2009 Oct; 194(2):119-24. PubMed ID: 19781444
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M
Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic aspects of myelodysplastic syndromes.
Bartram CR
Hematol Oncol Clin North Am; 1992 Jun; 6(3):557-70. PubMed ID: 1613006
[TBL] [Abstract][Full Text] [Related]
19. GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.
Guerenne L; Beurlet S; Said M; Gorombei P; Le Pogam C; Guidez F; de la Grange P; Omidvar N; Vanneaux V; Mills K; Mufti GJ; Sarda-Mantel L; Noguera ME; Pla M; Fenaux P; Padua RA; Chomienne C; Krief P
J Hematol Oncol; 2016 Jan; 9():5. PubMed ID: 26817437
[TBL] [Abstract][Full Text] [Related]
20. BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome.
Gorombei P; Guidez F; Ganesan S; Chiquet M; Pellagatti A; Goursaud L; Tekin N; Beurlet S; Patel S; Guerenne L; Le Pogam C; Setterblad N; de la Grange P; LeBoeuf C; Janin A; Noguera ME; Sarda-Mantel L; Merlet P; Boultwood J; Konopleva M; Andreeff M; West R; Pla M; Adès L; Fenaux P; Krief P; Chomienne C; Omidvar N; Padua RA
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
